These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

930 related items for PubMed ID: 32886420

  • 1. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M, Canu E, Donzuso G, Stojkovic T, Basaia S, Stankovic I, Tomic A, Markovic V, Petrovic I, Stefanova E, Kostic VS, Agosta F.
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [Abstract] [Full Text] [Related]

  • 2. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
    Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT.
    Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
    [Abstract] [Full Text] [Related]

  • 3. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A, Bedetti C, Degroot C, Mejia-Constain B, Lafontaine AL, Soland V, Chouinard S, Bruneau MA, Mellah S, Belleville S, Monchi O.
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [Abstract] [Full Text] [Related]

  • 4. Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature.
    Sarasso E, Agosta F, Piramide N, Filippi M.
    J Neurol; 2021 Sep; 268(9):3144-3179. PubMed ID: 32378035
    [Abstract] [Full Text] [Related]

  • 5. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J, Marecek R, Klobusiakova P, Balazova Z, Anderkova L, Nemcova-Elfmarkova N, Rektorova I.
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [Abstract] [Full Text] [Related]

  • 6. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW, Han YH, Mun CW, Chung EJ, Kim EG, Ji KH, Seo JH, Kim SJ.
    J Neurol Sci; 2014 Dec 15; 347(1-2):210-3. PubMed ID: 25451006
    [Abstract] [Full Text] [Related]

  • 7. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C, García-Lorenzo D, Garcia-Garcia D, Clavero P, Obeso JA, Lehericy S, Rodríguez-Oroz MC.
    Brain Imaging Behav; 2019 Feb 15; 13(1):180-188. PubMed ID: 28710667
    [Abstract] [Full Text] [Related]

  • 8. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX, Kang DZ, Chen FY, Liu Y, Wu G, Li X, Yu LH, Lin YX, Lin ZY.
    Neurosci Lett; 2016 Mar 23; 617():160-5. PubMed ID: 26742642
    [Abstract] [Full Text] [Related]

  • 9. Cortical Thinning and Cognitive Impairment in Parkinson's Disease without Dementia.
    Zhang L, Wang M, Sterling NW, Lee EY, Eslinger PJ, Wagner D, Du G, Lewis MM, Truong Y, Bowman FD, Huang X.
    IEEE/ACM Trans Comput Biol Bioinform; 2018 Mar 23; 15(2):570-580. PubMed ID: 29610105
    [Abstract] [Full Text] [Related]

  • 10. Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
    Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Garcia-Diaz AI, Vendrell P, Bargallo N, Tolosa E, Junque C.
    Mov Disord; 2014 Oct 23; 29(12):1495-503. PubMed ID: 25100674
    [Abstract] [Full Text] [Related]

  • 11. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H, Niccolini F, Pellicano C, Politis M.
    J Neurol Sci; 2019 Mar 15; 398():31-38. PubMed ID: 30682518
    [Abstract] [Full Text] [Related]

  • 12. Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?
    Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, Brooks DJ, Barker RA, Burn DJ, O'Brien JT.
    Mov Disord; 2016 Jan 15; 31(1):103-10. PubMed ID: 26202802
    [Abstract] [Full Text] [Related]

  • 13. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y, Nie K, Huang B, Mei M, Guo M, Xie S, Huang Z, Wang L, Zhao J, Zhang Y, Wang L.
    Neurosci Lett; 2017 Sep 29; 658():121-132. PubMed ID: 28823894
    [Abstract] [Full Text] [Related]

  • 14. Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
    Gorges M, Kunz MS, Müller HP, Liepelt-Scarfone I, Storch A, Dodel R, Hilker-Roggendorf R, LANDSCAPE Consortium, Berg D, Kalbe E, Braak H, Del Tredici K, Baudrexel S, Huppertz HJ, Kassubek J.
    Hum Brain Mapp; 2020 Apr 15; 41(6):1416-1434. PubMed ID: 31789477
    [Abstract] [Full Text] [Related]

  • 15. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
    Chung SJ, Yoo HS, Lee YH, Lee HS, Ye BS, Sohn YH, Kwon H, Lee PH.
    Hum Brain Mapp; 2019 Sep 15; 40(13):3784-3794. PubMed ID: 31090134
    [Abstract] [Full Text] [Related]

  • 16. Parietal memory network and memory encoding versus retrieval impairments in PD-MCI patients: A hippocampal volume and cortical thickness study.
    Sahin S, Velioglu HA, Yulug B, Bayraktaroglu Z, Yildirim S, Hanoglu L.
    CNS Neurosci Ther; 2024 Oct 15; 30(10):e70062. PubMed ID: 39380180
    [Abstract] [Full Text] [Related]

  • 17. Neuroanatomical changes in early Parkinson's disease with mild cognitive impairment: a VBM study; the Parkinson's Disease Cognitive Impairment Study (PaCoS).
    Donzuso G, Monastero R, Cicero CE, Luca A, Mostile G, Giuliano L, Baschi R, Caccamo M, Gagliardo C, Palmucci S, Zappia M, Nicoletti A.
    Neurol Sci; 2021 Sep 15; 42(9):3723-3731. PubMed ID: 33447925
    [Abstract] [Full Text] [Related]

  • 18. Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment.
    Uchida Y, Kan H, Sakurai K, Arai N, Kato D, Kawashima S, Ueki Y, Matsukawa N.
    Mov Disord; 2019 Aug 15; 34(8):1164-1173. PubMed ID: 31091347
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson's disease patients.
    Leocadi M, Canu E, Donzuso G, Stojkovic T, Basaia S, Kresojević N, Stankovic I, Sarasso E, Piramide N, Tomic A, Markovic V, Petrovic I, Stefanova E, Kostic VS, Filippi M, Agosta F.
    J Neurol; 2022 Mar 15; 269(3):1485-1500. PubMed ID: 34297177
    [Abstract] [Full Text] [Related]

  • 20. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M, Foo H, Chander RJ, Wen MC, Au WL, Sitoh YY, Tan L, Kandiah N.
    J Neurol Sci; 2017 Jun 15; 377():122-126. PubMed ID: 28477681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.